An exploration of recent M&A activity, using biological metaphors to explain the strategies behind corporate mergers and acquisitions, featuring case studies like Pfizer-Seagen.
Analysis of record-breaking M&A deals, AI-driven strategies, and geopolitical factors reshaping the 2025 corporate landscape